In addition, data also indicated that up‐regulated H19 could alleviate myocardial fibrosis as well as decrease the expression of pro‐fibrogenic mediators such as collagen I, collagen III and TGF‐β (Figure 1H, P < .05). This evidence concerns the gene H19 and Myocardial fibrosis.